Cara Therapeutics | CARA - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Acadia Pharmaceuticals USD 3.8B 724M 2026-03
Alterity Therapeutics Limited AUD 36M 20M 2026-06
Cara Therapeutics USD 366M 338M 2025-09
Cassava Sciences USD 96M 45M 2025-12
Chugai Pharma JPY 14.46T 617.89B 2026-03
Cipla INR 988.89B 231.9B 2026-03
Clal Biotechnology ILS 43.45M 8.92M 2026-03
CSL USD 55.89B 20.42B 2025-12
Halozyme Therapeutics USD 7.66B 257M 2026-03
J&J USD 579.15B 78.91B 2026-03
Neurocrine Biosciences USD 13.25B 890M 2026-03
Pacira USD 915M 149M 2026-03
Pfizer USD 153.81B 12.24B 2026-03
RedHill Biopharma USD 1000K 4M 2026-06
Supernus Pharmaceuticals USD 2.98B 126M 2026-03
Vanda Pharmaceuticals USD 279M 6M 2024-12